Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 129 (4) , 766-773
- https://doi.org/10.1016/0002-8703(95)90328-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Urodilatin binds to and activates renal receptors for atrial natriuretic peptide.Hypertension, 1993
- Haemodynamic and renal effects of urodilatin in healthy volunteersEuropean Journal of Clinical Investigation, 1992
- Urodilatin: Klinische Bedeutung des renalen natriuretischen PeptidsDeutsche Medizinische Wochenschrift (1946), 1991
- Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failureThe American Journal of Cardiology, 1990
- Hemodynamic, hormonal, and renal effects of atrial natriuretic peptide in untreated congestive cardiac failureAmerican Heart Journal, 1989
- Urodilatin: a newly described member of the ANP familyTrends in Pharmacological Sciences, 1989
- Isolation and structural analysis of “Urodilatin”, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urineJournal of Molecular Medicine, 1988
- Urodilatin (CDD/ANP‐95‐126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (α‐hANP/CDD‐99‐126)FEBS Letters, 1988
- HAEMODYNAMIC EFFECTS OF ATRIAL PEPTIDE INFUSION IN HEART FAILUREThe Lancet, 1986
- Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosaLife Sciences, 1984